Get the extension Sign in

Health

Most powerful obesity drug yet: People lost up to 25% of weight in trial

Summary

HealthClinical TrialEli LillyGipGlp 1

More than a third of participants taking retatrutide lost 30 percent or more of their weight. The drug also proved effective at reducing knee pain in a subset of participants with obesity-linked knee osteoarthritis.

Headline check

The one thing this headline claims is in the report.

Figures, names and quoted words in the headline, looked for in the report itself — not in the summary above. One claim in this headline could be checked, so this is a narrow pass and not a thorough one. How this is checked

This is a summary. The indicators are not. Every score on this page was measured over the full 978-word report, which is the only way the numbers mean anything.

How this outlet filed it, and how we rewrote it

No other newsroom we read has filed on this event, so there is nothing to compare it with yet.

Outlet Niral Score
Ars Technicaas they published this story 16.3

Sign in to react.

Comments are not open yet. They will be once there is someone to read every one before it appears. If something here is wrong, tell us — that we do read.